At Regional Cancer Care Associates (RCCA), our oncologists and hematologists have the expertise and experience, the commitment and the compassion, required to provide the cutting-edge care for cancer and blood disorders that you deserve.
We offer the most advanced treatments, including breakthroughs like immunotherapy and targeted therapy. At our 24 community-based care centers across New Jersey, Connecticut, Maryland, and the Washington, DC area, our oncologists and hematologists draw on their broad and deep experience to treat the full range of solid tumors, blood-based malignancies, and non-cancer blood disorders, such as anemia or clotting problems. Those community-based RCCA oncologists and hematologists work closely with their RCCA colleagues at the John Theurer Cancer Center of Hackensack University Medical Center, where each RCCA oncologist and hematologist focuses on a specific type of cancer or hematologic disorder. Patients can participate in a wide range of clinical trials at both our community-based centers and the John Theurer Cancer Center.
Whether you see an RCCA specialist at a community-based center near your home or at the John Theurer Cancer Center in Hackensack, you will receive comprehensive care from a highly capable physician and full clinical team dedicated to you and your health. At RCCA, we’re your partners – for life!
Founded January 1, 2012, by Dr. Andrew Pecora, Regional Cancer Care Associates formed after a merger of 10 separate oncology practices. In total, our team includes more than 110 cancer care specialists and 500 employees at 25 locations. Our broad reach extends across three states, making it convenient for our valued patients in Connecticut, Maryland, and New Jersey to receive the personalized medical attention they need and deserve.
Our member physicians and support staff have decades of experience in their respective communities. Thanks in part to this expertise, we are one of a handful of practices selected to implement the Oncology Care Model (OCM) for our patients. This Medicare initiative aims to improve all aspects of cancer care for beneficiaries receiving chemotherapy, allowing us to deliver the highest quality of treatment possible for more than 24,500 new patients annually and more than 245,000 existing patients.
RCCA President and CEO Terrill Jordan, now in his fifth year at the helm, guides our network of physicians on its mission to transform oncology care. Terrill leads the organization with a wealth of experience in many industries, including an extensive background in medical management. Today he draws on this expertise to oversee our delivery of cutting-edge treatments and the creation of compassionate, community-based settings for all our patients. This includes breakthroughs in immunotherapy and targeted therapy, as well as the most advanced remedies for cancer and blood disorders.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.